Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01409798 · ClinicalTrials.gov registry record

The Midwest Head and Neck Cancer Consortium Multi-Institutional Parathyroid Registry

A clinical trial, sponsored by University of Nebraska.

Completed
Registry status
175
Enrollment target

NCT01409798: Completed study, sponsored by University of Nebraska.

NCT01409798 is a clinical trial that has completed, run by University of Nebraska. The registered enrollment target is 175 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01409798 has completed, sponsored by University of Nebraska.

COMPLETED
Registry status
175 participants
Enrollment target

Study Summary

The purpose of this registry is to create a database that collects clinical data to improve knowledge about primary hyperparathyroidism.

Trial Details

FieldValue
Enrollment Target 175 participants
Start Date 2010-06-09
Est. Completion 2015-04-27
University of Nebraska

407 total trials

What the finished NCT01409798 record still lists

NCT01409798 is an observational study that tracks outcomes without assigning an intervention. The registered 175 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT01409798 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01409798 about?

NCT01409798 is a clinical study titled "The Midwest Head and Neck Cancer Consortium Multi-Institutional Parathyroid Registry". The purpose of this registry is to create a database that collects clinical data to improve knowledge about primary hyperparathyroidism.

What is the current status of trial NCT01409798?

This trial is currently completed. The enrollment target is 175 participants. The study started on 2010-06-09. Estimated completion is 2015-04-27.

Who is sponsoring clinical trial NCT01409798?

This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04722341 · 175 participants · NA

    Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators

  • NCT05094037 · 175 participants · NA

    Orthotic Treatment of Diabetic Foot Ulcers

  • NCT05165745 · 175 participants · NA

    Stick2PrEP Cisgender Women and Trans Individuals

  • NCT05312255 · 175 participants · NA

    Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01409798, the US trial registry maintained by the National Library of Medicine. NCT01409798 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.